Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Catheter Precision ( (VTAK) ) has shared an update.
Catheter Precision, Inc. has appointed Philip Anderson as the new Chief Financial Officer, effective January 6, 2025. The appointment signifies a leadership change aimed at enhancing the company’s financial strategy. With Anderson’s extensive experience across various industries, including technology and beverage distillation, the company anticipates strengthening its financial management and reporting. Anderson’s compensation package includes a base salary, stock options, and bonus eligibility, indicating a robust incentive structure to align his interests with the company’s growth objectives.
More about Catheter Precision
YTD Price Performance: 24.72%
Average Trading Volume: 3,687,666
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $4.48M
See more insights into VTAK stock on TipRanks’ Stock Analysis page.
